Acyclovir prophylaxis of oral herpes virus during bone marrow transplantation

Wade, 1984, Recurrent infection with herpes simplex virus after marrow transplantation: role of the specific immune response and acyclovir treatment, J Infect Dis, 149, 750, 10.1093/infdis/149.5.750 Wade, 1984, Oral acyclovir for prevention of herpes simplex virus reactivation after marrow transplantation, Ann Intern Med, 100, 823, 10.7326/0003-4819-100-6-823 Lam, 1981, Herpes simplex infection in acute myelogenous leukemia and other hematologic malignancies: prospective study, Cancer, 48, 2168, 10.1002/1097-0142(19811115)48:10<2168::AID-CNCR2820481009>3.0.CO;2-B Rand, 1982, Cancer chemotherapy associated symptomatic stomatitis: role of herpes simplex virus (HSV), Cancer, 56, 1262, 10.1002/1097-0142(19821001)50:7<1262::AID-CNCR2820500707>3.0.CO;2-F Strauss, 1984, Oral acyclovir to suppress recurring herpes simplex virus infections in immunodeficient patients, Ann Intern Med, 100, 522, 10.7326/0003-4819-100-4-522 Meyers, 1988, Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation, N Engl J Med, 30, 17 Schubert, 1990, Truelove EL. Oral and pharyngeal herpes simplex infection after allogeneic bone marrow transplantation: analysis of factors associated with infection, Oral Surg Oral Med Oral Pathol, 70, 286, 10.1016/0030-4220(90)90142-F Woo, 1990, The role of herpes simplex virus in the development of oral mucositis in bone marrow transplant recipients, Cancer, 66, 2375, 10.1002/1097-0142(19901201)66:11<2375::AID-CNCR2820661121>3.0.CO;2-6 Shibuya, 1989, Herpes simplex virus in oral mucosal ulcers in patients with hematological malignancy, Jap J Clin Oncol, 19, 348 Redding, 1990, Role of herpes simplex virus reactivation in chemotherapy-induced oral mucositis, NCI Monogr, 9, 103 Schubert, 1993, Oral infections due to cytomeglovirus in immunocompromised patients, J Oral Pathol Med, 22, 268, 10.1111/j.1600-0714.1993.tb01069.x Selby, 1989, after allogeneic bone marrow transplantation, Br J Cancer, 59, 434, 10.1038/bjc.1989.88 Epstein, 1991, Antiviral therapeutics in dentistry, Curr Op Dent, 1, 436 Meyers, 1989, Chemoprophylaxis of viral infection in immuno-compromised patients, Eur J Cancer Clin Oncol, 25, 1369, 10.1016/0277-5379(89)90089-8 Balfour, 1989, Acyclovir prevents cytomegalovirus disease in renal allograft recipients, N Engl J Med, 320, 384, 10.1056/NEJM198905253202105 Reed, 1990, Ganciclovir for the treatment of cytomegalovirus gastroenteritis in bone-marrow-transplant patients, Ann Intern Med, 112, 505, 10.7326/0003-4819-112-7-505 Ho, 1989, Tolerance and efficacy of ganciclovir in the treatment of cytomegalovirus infections in immunosuppressed patients, 21, 3103 Rubie, 1993, Risk factors for cytomeglovirus infection in BMT recipients transfused exclusively with seronegtive blood products, Bone Marrow Transplant, 11, 209 Bacigaulupo, 1992, CMV infections following allogeneic BMT: risk factors, early treatment and correlation with transplant related mortality, Hematologica, 77, 507 Winston, 1993, Ganciclovir prophylaxis of cytomegalovirus infection and disease in allogeneic bone marrow transplant recipients. Results of a placebo-controlled, double-blind trial, Ann Intern Med, 118, 179, 10.7326/0003-4819-118-3-199302010-00004 Englund, 1990, Herpes simplex virus resistant to acyclovir: a study in a tertiary care center, Ann Intern Med, 112, 416, 10.7326/0003-4819-76-3-112-6-416 Wade, 1983, Frequency and significance of acyclovir-resistant herpes simplex virus isolated from marrow transplant patients receiving multiple courses of treatment with acyclovir, J Infect Dis, 148, 1077, 10.1093/infdis/148.6.1077 Epstein, 1991, Herpes simplex virus in immuno-compromised patients: growing evidence of drug resistance, Oral Surg Oral Med Oral Pathol, 72, 47, 10.1016/0030-4220(91)90188-I Erice, 1989, Progressive disease due to ganciclovir resistant cytomegalovirus in immunocompromised patients, N Engl J Med, 320, 289, 10.1056/NEJM198902023200505 Stanat, 1991, Ganciclovir-resistant cytomegalovirus clinical isolates: mode of resistance to ganciclovir, Antimicrob Agents Chemother, 35, 2191, 10.1128/AAC.35.11.2191 Sullivan, 1991, Isolation of foscarnet-resistant human cytomegalovirus patterns of resistance and sensitivity to other antiviral durgs, J Infect Dis, 164, 781, 10.1093/infdis/164.4.781 Biron, 1991, Ganciclovir-resistant human cytomegalovirus clinical isolates; resistance mechanisms and in vitro susceptibility to antiviral agents, 23, 162 Knox, 1991, Cytomegalovirus isolate resistant to ganciclovir and foscarnet from a marrow transplant patient, Lancet, 337, 1292, 10.1016/0140-6736(91)92965-5 Drew, 1991, Clinical use of ganciclovir for cytomegalovirus infection and the development of drug ressitance, JAIDS, 4, s42 Field, 1982, Development of clinical resistance to acyclovir in herpes-simplex-virus-infected mice receiving oral therapy, Antimicrob Agents Chemother, 21, 744, 10.1128/AAC.21.5.744 Field, 1980, Isolation and characterization of acyclovir-resistant mutants of herpes simplex virus, J Gen Virol, 49, 115, 10.1099/0022-1317-49-1-115 Parris, 1982, Herpes simplex virus variants resistant to high concentrations of acyclovir exist in clinical isolates, Antimicrob Agents Chemother, 22, 71, 10.1128/AAC.22.1.71 Erlich, 1989, Acyclovir-resistant herpes simplex virus infections in patients with the acquired immuno-deficiency syndrome, N Engl J Med, 320, 293, 10.1056/NEJM198902023200506 Bean, 1987, Progressive mucocutaneous herpes simplex infection due to acyclovir-resistant virus in an immunocompromised patient: correlation of viral susceptibilities and plasma levels with response to therapy, Diag Microbiol Infect Dis, 7, 199, 10.1016/0732-8893(87)90005-8 MacPhail, 1989, Acyclovir-resistant, foscarnet-sensitive oral herpes simplex type II lesion in a patient with AIDS, Oral Surg Oral Med Oral Pathol, 67, 427, 10.1016/0030-4220(89)90386-1 Crumpacker, 1988, Significance of resistance of herpes simplex virus to acyclovir, J Am Acad Dermatol, 18, 190, 10.1016/S0190-9622(88)70026-2 Ljungman, 1990, Acyclovir-resistant herpes simplex virus causing pneumonia after marrow transplantation, J Infect Dis, 162, 244, 10.1093/infdis/162.1.244 Englund, 1990, Herpes simplex virus resistant to acyclovir. A study in a tertiary care center, Ann Intern Med, 112, 416, 10.7326/0003-4819-76-3-112-6-416 Gray, 1989, Susceptibility to acyclovir of herpes simplex virus: emergence of resistance in patients with lymphoid and myeloid neoplasia, J Infection, 19, 31, 10.1016/S0163-4453(89)94798-1 Nevill, 1992, Influence of post-methotrexate follinic acid rescue on regimen-related toxicity and graft-versus-host disease after allogeneic bone marrow transplantation, Bone Marrow Transplant, 9, 349 Epstein, 1990, Clinical study of herpes simplex virus infection in leukemia, Oral Surg Oral Med Oral Pathol, 70, 38, 10.1016/0030-4220(90)90175-R Epstein, 1987, The role of an immunoperoxidase technique in the diagnosis of oral herpes simplex virus infection in patients with leukemia, Clin Cytopathol, 3, 206, 10.1002/dc.2840030306 Cohen, 1985, Chronic oral herpes simplex virus infection in immunocompromised patients, Oral Surg Oral Med Oral Pathol, 56, 465, 10.1016/0030-4220(85)90085-4 Greenberg, 1987, Oral herpes simplex infections in patients with leukemia, J Am Dent Assoc, 114, 483, 10.14219/jada.archive.1987.0120 Herzig, 1983, High-dose cytosine arabinoside therapy for refractory leukemia, Blood, 62, 361, 10.1182/blood.V62.2.361.361 Glucksberg, 1974, Clinical manifestations of graft-versus-host disease in human recipients of HLA-matched sibling donors, Transplantation, 18, 295, 10.1097/00007890-197410000-00001 Weisdorf, 1990, Acute upper gastrointestinal graft-versus-host disease: clinical significance and response to immunosuppressive therapy, Blood, 76, 624, 10.1182/blood.V76.3.624.624 Hawkes, 1979, General principles underlying laboratory diagnosis of viral infections Epstein, 1991, Viral serology after bone marrow transplantation, Viral Immunol, 4, 133, 10.1089/vim.1991.4.133 Epstein, 1987, Oral mucosal lesions in patients undergoing treatment for leukemia, J Oral Med, 42, 132 Wingard, 1990, Infectious and noninfectious systemic consequences, NCI Monogr, 9, 21 Ringden, 1984, Decreased incidence of viridans streptococcal septicaemia in allogeneic bone marrow transplant recipients after the introduction of acyclovir, Lancet, 1, 744, 10.1016/S0140-6736(84)92259-1 Donnelly, 1993, Failure of clindamycin to influence the course of severe oromucositis associated with streptococcal bacteraemia in allogeneic bone marrow transplant recipients, Scand J Infect Dis, 25, 43, 10.3109/00365549309169668 Redding, 1989, Acyclovir prophylaxis for oral herpes simplex virus infection in patients with bone marrow transplants, Oral Surg Oral Med Oral Pathol, 67, 680, 10.1016/0030-4220(89)90008-X Shepp, 1985, Oral acyclovir therapy for mucocutaneous herpes simplex virus infection in immunocompromised marrow transplant recipients, Ann Intern Med, 102, 783, 10.7326/0003-4819-102-6-783 Prentice, 1983, Use of acyclovir for prophylaxis of herpes infections in several immunocompromised patients, J Antimicrob Chemother, 12, 153, 10.1093/jac/12.suppl_B.153 Sacks, 1989, Progressive esophagitis from acyclovir-resistant herpes simplex: clinical roles for DNA polymerase mutants and viral heterogeneity, Ann Intern Med, 111, 893, 10.7326/0003-4819-111-11-893 Chatis, 1989, Successful treatment with foscarnet of an acyclovir-resistant mucocutaneous infection with herpes simplex virus in a patient with acquired immunodeficiency syndrome, N Engl J Med, 320, 297, 10.1056/NEJM198902023200507 Prentice, 1994, Impact of long-term acyclovir on cytomegalovirus infection and survival after allogeneic bone marrow transplantation, Lancet, 343, 749, 10.1016/S0140-6736(94)91835-X Ljungman, 1993, Cytomegalovirus viremia and specific T-helper cell responses as predictors of disease after allogeneic marrow transplantation, Br J Haematol, 83, 118, 10.1111/j.1365-2141.1993.tb04641.x Bostrom, 1991, Strong donor mononuclear cell reactivity for herpes simplex virus (HSV) antigen in HSV immune donors combined with recipient seropositivity for HSV is associated with acute graft-versus-host disease, Scand J Immunol, 34, 45, 10.1111/j.1365-3083.1991.tb01519.x